These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7904993)

  • 1. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
    Amarapurkar DN; Parikh SS; Desai HG
    J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
    Gilinsky NH; Bright-Asare P; Cobert BL; Fitch DD; Lanza FL; Kerr RM; Savitsky JP
    Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
    J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
    Inoue M
    Drugs; 1988; 35 Suppl 3():114-9. PubMed ID: 2905239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of roxatidine acetate: a review.
    Dammann HG; de Looze SM; Bender W; Labs R
    Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
    Hüttemann W
    Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study Group.
    Clin Ther; 1991; 13(1):47-57. PubMed ID: 1674231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of oxmetidine and cimetidine in the treatment of duodenal ulcer.
    Barbezat GO; Brown D; Schlup M; Maclaurin BP
    N Z Med J; 1983 Apr; 96(729):250-2. PubMed ID: 6340009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparative study of cimetidine and placebo in adult Nigerian duodenal ulcer patients with special reference to gastroduodenal mucosal morphology and intestinal bacterial activity.
    Falaiye JM; Popoola AO
    Afr J Med Med Sci; 1979; 8(1-2):61-70. PubMed ID: 122333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
    Fock KM; Kang JY; Ng HS; Ng TM; Gwee KA; Lim CC
    J Gastroenterol Hepatol; 1995; 10(4):379-82. PubMed ID: 8527701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.
    Hentschel E; Schütze K
    Drugs; 1988; 35 Suppl 3():96-101. PubMed ID: 2905256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind controlled trial with oxmetidine and cimetidine in the short-term treatment of duodenal ulcer.
    Corinaldesi R; Galassi A; Borghi C; Pasquali R; Miglioli M; Sacco T; Barbara L
    Hepatogastroenterology; 1981 Dec; 28(6):319-21. PubMed ID: 7047341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
    Hüttemann W
    Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
    Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
    J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled comparison of sucralfate and cimetidine in duodenal ulcer.
    Hentschel E; Schütze K; Dufek W
    Scand J Gastroenterol Suppl; 1983; 83():31-5. PubMed ID: 6356318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Misoprostol and cimetidine in the treatment of active duodenal ulcer. Multicenter, double-blind, clinico-endoscopic study. The Argentine experience].
    Baccaro JC; González del Solar C; Laudanno O; Mauro E; Mazure PA; Pardo R; Pulpeiro A; Rubio H; Tomatis H
    Acta Gastroenterol Latinoam; 1987; 17(3):235-40. PubMed ID: 3145665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind endoscopic study with De-Nol tablets and cimetidine for duodenal ulcer.
    Bianchi Porro G; Petrillo M; De Nicola C; Lazzaroni M
    Scand J Gastroenterol; 1984 Oct; 19(7):905-8. PubMed ID: 6397848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.